Silver Spring, Maryland—(ENEWSPF)—December 18, 2017
By: Lyndsay Meyer
Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approachto drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and/or conditions but where the products have not been shown to offer clinical benefits.…
